Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$62.00 USD
-1.31 (-2.07%)
Updated Oct 1, 2024 03:59 PM ET
After-Market: $61.80 -0.20 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/23/2024
Time: -- |
9/2024 | $-0.24 | -7.00% |
Earnings Summary
For their last quarter, Viking Therapeutics (VKTX) reported earnings of -$0.20 per share, beating the Zacks Consensus Estimate of $-0.26 per share. This reflects a positive earnings surprise of 23.08%. Look out for VKTX's next earnings release expected on October 23, 2024. For the next earning release, we expect the company to report earnings of -$0.24 per share, reflecting a year-over-year decrease of 4.35%.
Earnings History
Price & Consensus
Zacks News for VKTX
Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services